Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 2 hrs 55 mins

S&P Futures
5,870.25
-26.00(-0.44%)
Dow Futures
42,986.00
-191.00(-0.44%)
Nasdaq Futures
20,407.00
-112.50(-0.55%)
Russell 2000 Futures
2,237.80
-17.70(-0.78%)
Crude Oil
71.29
+0.73(+1.03%)
Gold
2,749.80
+10.90(+0.40%)

BioInvent International AB (publ) (0H22.IL)

IOB - IOB Delayed Price. Currency in SEK

Follow

44.95

+0.85

(+1.93%)

As of 11:56AM BST. Market open.

Currency in SEK

Valuation Measures⁴

Market Cap (intraday)	2.85B
Enterprise Value	1.80B
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	56.47
Price/Book (mrq)	2.71
Enterprise Value/Revenue	34.24
Enterprise Value/EBITDA	-20.59

Trading Information

Stock Price History

Beta (5Y Monthly)	0.28
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	48.90
52 Week Low ³	14.35
50-Day Moving Average ³	42.87
200-Day Moving Average ³	29.63

Share Statistics

Avg Vol (3 month) ³	655
Avg Vol (10 day) ³	619
Shares Outstanding ⁵	65.8M
Implied Shares Outstanding ⁶	N/A
Float ⁸	34.14M
% Held by Insiders ¹	11.10%
% Held by Institutions ¹	54.83%
Shares Short ⁴	N/A
Short Ratio ⁴	N/A
Short % of Float ⁴	N/A
Short % of Shares Outstanding ⁴	N/A
Shares Short (prior month ) ⁴	N/A

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	1:25
Last Split Date ³	Dec 14, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2022
Most Recent Quarter (mrq)	Jun 30, 2023

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-479.58%

Management Effectiveness

Return on Assets (ttm)	-12.90%
Return on Equity (ttm)	-20.67%

Income Statement

Revenue (ttm)	67.91M
Revenue Per Share (ttm)	1.04
Quarterly Revenue Growth (yoy)	-95.20%
Gross Profit (ttm)	326.13M
EBITDA	-316.2M
Net Income Avi to Common (ttm)	-304.28M
Diluted EPS (ttm)	-5.01
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	1.1B
Total Cash Per Share (mrq)	16.73
Total Debt (mrq)	23.13M
Total Debt/Equity (mrq)	1.57
Current Ratio (mrq)	11.06
Book Value Per Share (mrq)	22.43

Cash Flow Statement

Operating Cash Flow (ttm)	-61.95M
Levered Free Cash Flow (ttm)	43.93M